Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
A completed real-world study evaluating the effectiveness and safety of ranibizumab in patients with wet age-related macular degeneration, d…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports systemic pharmacokinetics after intravitreal injections of an anti-VEGF agent.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Reduction in the Occurrence of Center-Involved Diabetic Macular Edema [Phase 3]
A Phase 3 clinical trial update reports a reduction in center-involved diabetic macular edema in patients with diabetic retinopathy; results…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema [Phase 4]
Phase 4 clinical trial assessing the efficacy of intravitreal Triamcinolone and Bevacizumab for diabetic macular edema; study status is COMP…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Ranibizumab and Bevacizumab for Diabetic Macular Edema [Phase 2]
Phase 2 clinical trial comparing ranibizumab and bevacizumab for diabetic macular edema has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab [Phase 1, Phase 2]
Results from a Phase 1/2 study evaluating ranibizumab at 0.5 mg and 2.0 mg for diabetic macular edema in patients with poor response to beva…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema [Phase 4]
A Phase 4 clinical trial comparing anti-VEGF monotherapy to anti-VEGF combined with EPM grid laser therapy for diabetic macular edema.
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement [Phase 3]
Phase 3 trial evaluating the efficacy and safety of VEGF Trap-Eye (aflibercept) for diabetic macular edema with central involvement; the stu…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema [Phase 4]
Phase 4 study comparing intraocular anti-VEGF therapy with intraocular triamcinolone for diabetic macular edema; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment [Phase 2]
This Phase 2 trial evaluated intravitreal ranibizumab with deferred laser grid photocoagulation for diabetic macular edema with visual impai…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Effect of Ruboxistaurin on Clinically Significant Macular Edema [Phase 3]
Phase 3 trial evaluating ruboxistaurin for clinically significant macular edema in diabetes has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema
A completed clinical trial update examining how retinal structural and functional measurements relate to visual acuity in eyes treated for d…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) [Phase 1]
Regeneron reports the completion of a Phase 1 study evaluating intravitreal REGN910-3 and REGN910 for neovascular age-related macular degene…
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema [Phase 4]
Phase 4 clinical trial evaluating the efficacy of combined ranibizumab and aflibercept therapy in diabetic macular edema; the study status i…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema [Phase 3]
Phase 3 comparative effectiveness study of intravitreal aflibercept, bevacizumab, and ranibizumab for diabetic macular edema has completed w…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: The Effect of Intravitreal Ozurdex on DME After Cataract Surgery [Phase 3]
Phase 3 trial evaluating intravitreal Ozurdex for diabetic macular edema following cataract surgery has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema [Phase 4]
A Phase 4 trial comparing anti-VEGF therapy alone versus Ozurdex (dexamethasone intravitreal implant) given every 3 months for persistent di…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001) [Phase 2]
A Phase 2 study of MK0140 in diabetic patients with macular edema has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy
The completed trial evaluated changes in visual acuity in patients with diabetic macular edema who started treatment with an approved anti-V…
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating MTP-131 topical ophthalmic solution for diabetic macular e…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function
Clinical trial update reporting completion of a study validating a new methodology for mapping the human blood-retinal barrier function, inv…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Grid Laser for Diffuse Diabetic Maculopathy
A clinical trial evaluating grid laser treatment for diffuse diabetic macular edema has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy [Phase 4]
A Phase 4, non-randomized, open-label study assessing the effect and safety of the ILUVIEN fluocinolone acetonide intravitreal implant in ch…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies
Observational study assessing the effect of Iluvien (fluocinolone acetonide intravitreal implant) in diabetic macular edema patients unrespo…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: A Study of Abicipar Pegol in Patients With Diabetic Macular Edema [Phase 2]
A Phase 2 trial evaluating Abicipar Pegol for diabetic macular edema has completed.